-
In a study of 82 patients with primary dysmenorrhea who had been randomized to undergoing either LUNA or LUNA + PN, the two groups had comparable results (69% improved in the LUNA group; 73% in the LUNA+PN group) at up to 12 months of follow-up.
-
Wilkinson and colleagues from the University of Texas in Galveston analyzed information from the Surveillance, Epidemiology, and End Results (SEER) databank linked to Medicare claims.
-
-
-
Between 2000 and 2004 these French investigators studied 2863 women to determine the frequency of reported symptoms (weight gain, nausea, breast tenderness, swollen legs, fewer periods, breakthrough bleeding, painful/heavy periods) relative to the type of OCP taken (estrogen dose, progestin component, sequence of administration).
-
It is still common practice to exteriorize the uterus during repair of the uterine incision during cesarean section. The rationale to support this maneuver is that it makes the job easier, faster, and it decreases blood loss.
-
The title says it all in this randomized controlled trial by Sullivan and colleagues "Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing post-cesarean infectious morbidity."
-
Zometa and hip fractures; Merck HIV Vaccine Ineffective in Clinical Trial; Thimerosal and Mercury Exposure; FDA Actions
-
It is one thing to be empathetic, but it is something quite different to be able to convey empathy to the patient.
-
WISDOM was a multicenter, randomized, placebo-controlled clinical trial of postmenopausal hormone therapy that began recruitment in 1999 in the U.K. and in 2000 in Australia and New Zealand. The trial was prematurely cancelled in 2002 after the initial publication of results in the Women's Health Initiative (WHI).